Home › Esophageal Cancer › Pennsylvania › York
Esophageal Cancer clinical trials in York, PA
4 studies for Esophageal Cancer are looking for participants at sites in and around York (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Pan-tumor MRD Study
RecruitingObservational study
- Cancer Care Associates of York (CCAY), York
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RecruitingObservational study
- WellSpan Medical Oncology & Hematology at York Cancer Center, York
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RecruitingPhase 3
- Research Site, York
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RecruitingPhase 1/2
- Cancer Care Associates of York (site 206), York
About Esophageal Cancer
Early esophageal cancer does not have symptoms. Factors that increase risk include heavy drinking and smoking. Learn how you can reduce your risk.
More about Esophageal Cancer on MedlinePlus
Esophageal Cancer trials in other cities
- Houston, TX36 studies
- Boston, MA23 studies
- New York City, NY22 studies
- Nashville, TN19 studies
- St. Louis, MO17 studies
- Pittsburgh, PA15 studies
- Los Angeles, CA15 studies
- Baldwin Park, CA14 studies
- Grand Rapids, MI14 studies
- Philadelphia, PA13 studies
- San Antonio, TX12 studies
- Rochester, MN11 studies
Other studies in York
- Non-Small Cell Lung Cancer15 studies
- Cancer (all types)8 studies
- Breast Cancer8 studies
- Lung Cancer8 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- Ovarian Cancer6 studies
- Prostate Cancer5 studies
- Coronary Artery Disease5 studies
- Triple-Negative Breast Cancer4 studies
- Colorectal Cancer4 studies
- Endometrial Cancer4 studies
- Colon Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.